Effectiveness of Seven and Thirteen Valent Pneumococcal Conjugate Vaccines in a Schedule without a Booster dose: a Ten Year Observational Study
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 23 Feb 2018
S Jayasinghe, C Chiu, H Quinn, R Menzies, R Gilmour and P McIntyre
Uniquely among high income countries, Australia uses a 3+0 schedule (3 primary doses; no booster) for infant pneumococcal conjugate vaccine since January 2005, initially 7-valent (PCV7) then 13-valent (PCV13) from July 2011. We measured vaccine effectiveness (VE) of both PCVs against invasive pneumococcal disease (IPD) by two methods.
* Data courtesy of Altmetric.com